YJ
Yasmin Jamal Ansari Hasan Ul Banna
About Yasmin Jamal Ansari Hasan Ul Banna
Data last updated:
Yasmin Jamal Ansari Hasan Ul Banna is a Director at Rexha Pharmaceuticals Private Limited (since 2023). The company operates in Chemicals. Rexha Pharmaceuticals Private Limited reported revenue of ₹6 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rexha Pharmaceuticals Private Limited U24290PN2022PTC209097 | Director | 01 Mar 2023 | 2022 | ₹6 Lakh (FY 2025) | Active |
Board colleagues of Yasmin Jamal Ansari Hasan Ul Banna
| Name | DIN | Company | Designation |
|---|---|---|---|
| Haris Safwan Khan | 09526868 | Rexha Pharmaceuticals Private Limited | Director |
| Nawab Naim Ahmad Khan Niyazi | 09526869 | Rexha Pharmaceuticals Private Limited | Director |
| Taheruzzaman Khan Abiduzzaman Khan | 09526870 | Rexha Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yasmin Jamal Ansari Hasan Ul Banna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yasmin Jamal Ansari Hasan Ul Banna
Yasmin Jamal Ansari Hasan Ul Banna currently holds 1 directorship: Rexha Pharmaceuticals Private Limited (Director, since 01 Mar 2023, revenue ₹6 Lakh (FY 2025)).
Yasmin Jamal Ansari Hasan Ul Banna was first appointed on 01 Mar 2023 as Director at Rexha Pharmaceuticals Private Limited.
The current boards of Yasmin Jamal Ansari Hasan Ul Banna's companies include Haris Safwan Khan (Rexha Pharmaceuticals Private Limited), Nawab Naim Ahmad Khan Niyazi (Rexha Pharmaceuticals Private Limited), Taheruzzaman Khan Abiduzzaman Khan (Rexha Pharmaceuticals Private Limited).